EA Pharma has acquired Drasanvi

Target
Company Name
Target
Country
Description

EA Pharma has acquired a majority stake of the capital of Drasanvi.
ANQUOR Corporate Finance acted as a sole advisor to the seller.

Drasanvi is a leading Spanish company in the food supplements, natural cosmetics and health nutrition sector. With more than 25 years of experience, the Group is a reference player in the field of health, beauty and wellbeing thanks to its high-quality products of natural origin. The company markets brands such as Super Alimentos, Collmar, Botanical Bio, Vital Pur, Immunol or Oseogen.

Global M&A Offices
Anquor Corporate Finance (Global M&A Spain)
Global M&A Advisory Advisor to the seller